Peripheral Arterial Disease Trial, Recruiting (NCT01524276)

Peripheral Arterial Disease Trial, Recruiting NCT01524276 Sponsor: Medtronic Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT01524276 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

A patient, or their legal guardian or representative, must provide written consent or authorisation as required by the hospital or country where the trial is taking place
The patient has received, is currently receiving, or is planned to receive treatment with a qualifying Medtronic medical device
The patient is enrolling within the allowed time period relative to when their treatment started, or meets the conditions for being enrolled after treatment has already begun (confirm with trial site)

Who may not be able to join:

People who are unlikely to be available or reachable for follow-up appointments after joining the trial
People who are excluded based on rules required by the laws of their local area or country
People who are currently enrolled in, or are planning to join, another drug or medical device study at the same time that could affect the results of this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Australian sites

, Westmead, New South Wales

, Chermside,

, Murdoch,

, Southport,

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01524276

Sponsor: Medtronic

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

More information: https://clinicaltrials.gov/study/NCT01524276

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

A patient, or their legal guardian or representative, must provide written consent or authorisation as required by the hospital or country where the trial is taking place
The patient has received, is currently receiving, or is planned to receive treatment with a qualifying Medtronic medical device
The patient is enrolling within the allowed time period relative to when their treatment started, or meets the conditions for being enrolled after treatment has already begun (confirm with trial site)

Who may not be able to join:

People who are unlikely to be available or reachable for follow-up appointments after joining the trial
People who are excluded based on rules required by the laws of their local area or country
People who are currently enrolled in, or are planning to join, another drug or medical device study at the same time that could affect the results of this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medtronic

Registry

ClinicalTrials.gov

Start date

1 January 2012

Est. completion

1 January 2040

Where this trial is recruiting

🇦🇷 Argentina 🇦🇺 Australia 🇦🇹 Austria 🇧🇪 Belgium 🇧🇷 Brazil 🇨🇦 Canada 🇨🇳 China 🇨🇴 Colombia 🇨🇿 Czechia 🇩🇰 Denmark 🇫🇮 Finland 🇫🇷 France 🇩🇪 Germany 🇬🇷 Greece Hong Kong 🇭🇺 Hungary 🇮🇳 India 🇮🇪 Ireland 🇮🇱 Israel 🇮🇹 Italy 🇯🇵 Japan Kuwait 🇲🇾 Malaysia 🇲🇽 Mexico 🇳🇱 Netherlands 🇳🇿 New Zealand 🇳🇴 Norway Panama 🇵🇱 Poland 🇵🇹 Portugal Puerto Rico 🇸🇦 Saudi Arabia 🇷🇸 Serbia 🇸🇰 Slovakia 🇰🇷 South Korea 🇪🇸 Spain 🇸🇪 Sweden 🇨🇭 Switzerland 🇹🇼 Taiwan 🇬🇧 United Kingdom 🇺🇸 United States

4 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Safety and Effectiveness of Market Released products

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov